Mark A. Tepper

2.6k citations

36 papers · 2.1k indexed · 1 hit paper · h-index 19

Impact in

Immunology top 2%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Toxin Mechanisms and Immunotoxins
Transplantation top 5%

Papers in

Immunology 16
- Toxin Mechanisms and Immunotoxins 7
- Immune Response and Inflammation 5
Biotechnology 5

Co-authors: Steven G. Nadler Jeffrey A. Ledbetter Peter S. Linsley Jennifer Johnson Philip M. Wallace Marylou G. Gibson Bernice Schacter Charles E. Mazzucco
Journals: Annals of the New York Academy of Sciences (5 papers)Science (3 papers)The Journal of Immunology (2 papers)Journal of Interferon & Cytokine Research (2 papers)Transplantation (2 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Mark A. Tepper

36 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation Molecule 1992 · 692 citations

Peers

Countries citing papers authored by Mark A. Tepper

Since Specialization

Citations

This map shows the geographic impact of Mark A. Tepper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Tepper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Tepper more than expected).

Fields of papers citing papers by Mark A. Tepper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Tepper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Tepper. The network helps show where Mark A. Tepper may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark A. Tepper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Tepper Line = papers co-authored together Mark A. Tepper links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosis Journal of Cystic Fibrosis ·Abdullah A. Tarique, Tama Evron, George Zhang, Mark A. Tepper, 清水暁美, Sufian M. Mahmoud, Nelufa Begum, Peter D. Sly, Emmanuelle Fantino	2020	15
2	Treating exuberant, non-resolving inflammation in the lung; Implications for acute respiratory distress syndrome and COVID-19 Pharmacology & Therapeutics ·Derek W. Gilroy, Roel P. H. De Maeyer, Mark A. Tepper, Alastair O’Brien, Mohib Uddin, Judy Chen, Daniel R. Goldstein, Arne N. Akbar	2020	8
3	Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity Bioorganic & Medicinal Chemistry ·Mark A. Tepper, Robert B. Zurier, Sumner Burstein	2014	48
4	Formation of Human IFN- β Complex with the Soluble Type I Interferon Receptor IFNAR-2 Leads to Enhanced IFN Stability, Pharmacokinetics, and Antitumor Activity in Xenografted SCID Mice Journal of Interferon & Cytokine Research ·Sean D. McKenna, Mar韆 Cecilia Lorenzo, Antonio R. Arulanandam, W Y Weiser, Roustem Nabioullin, Mark A. Tepper	2004	30
5	Military Infrared Technology Advances Diabetes Research Diabetes Technology & Therapeutics ·Mark A. Tepper, Rebecca L. Persinger, Mohammad Arif Rivai, Zheng Rongxian, Raimundo Nonato Sousa Filho	2003	3
6	The Neutralization of Type I IFN Biologic Actions by Anti-IFNAR-2 Monoclonal Antibodies Is Not Entirely Due to Inhibition of Jak-Stat Tyrosine Phosphorylation Journal of Interferon & Cytokine Research ·Daniela Novick, Roustem Nabioullin, Francisco Cristino Moreira Neto, Sean D. McKenna, W Y Weiser, K. Grossman, Nguyen Tran Tram Anh, Soohyun Kim, Menachem Rubinstein, Mark A. Tepper, Antonio R. Arulanandam	2000	18
7	Specific binding of Fyn and phosphatidylinositol 3‐kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains European Journal of Immunology ·N. Jan Chalupny, A Aruffo, James M. Esselstyn, Eva Lailatul Manjilah, Jürgen Bajorath, James Blake, Lisa K. Gilliland, Jeffrey A. Ledbetter, Mark A. Tepper	1995	46
8	Elucidating the Mechanism of Action of the Immunosuppressant 15-Deoxyspergualin Therapeutic Drug Monitoring ·Steven G. Nadler, HANNAH CARMELA V. MARQUEZ, Mark A. Tepper, Fadilla Saffitriyani	1995	37
9	Quantitation of the Interaction of the Immunosuppressant Deoxyspergualin and Analogs with Hsc70 and Hsp90 Biochemistry ·Kari C. Nadeau, Steven G. Nadler, Mark G. Saulnier, Christopher T. Walsh, Mark A. Tepper	1994	98
10	Suppression of Human Anti-Mouse Antibody Response to Murine Monoclonal Antibody L6 by Deoxyspergualin: A Phase I Study Advances in experimental medicine and biology ·Kapil Dhingra, Daniel J. Booser, Aman U. Buzdar, Martin N. Raber, Lia Gutiérrez, Gabriel Hortobagyi, Herbert A. Fritsche, James L. Murray, Jan Swammerdam, M.B. Khazaeli, Susan L. Kelley, Mark A. Tepper, Douglas S. Greene	1994	5
11	PREVENTION OF THE HUMORAL RESPONSE INDUCED BY AN ANTI-CD3 MONOCLONAL ANTIBODY BY DEOXYSPERGUALIN IN A MURINE MODEL1 Transplantation ·Maria‐Luisa Alegre, Husain Sattar, Kevan C. Herold, Judy Smith, Mark A. Tepper, Jeffrey A. Bluestone	1994	8
12	Prevention of immunotoxin-mediated vascular leak syndrome in rats with retention of antitumor activity. Proceedings of the National Academy of Sciences ·Clay B. Siegall, Denny Liggitt, Dana F. Chace, Mark A. Tepper, H. Perry Fell	1994	47
13	15‐Deoxyspergualin: A Novel Immunosuppressive Drug with Clinical Potentiala Annals of the New York Academy of Sciences ·Francis T. Thomas, Mark A. Tepper, Judith M. Thomas, Carl E. Haisch	1993	24
14	Studies on the Interaction of the Immunosuppressant 15‐Deoxyspergualin with Heat Shock Proteins Annals of the New York Academy of Sciences ·Steven G. Nadler, Jeffrey S. Cleaveland, Mark A. Tepper, Christopher T. Walsh, Kari C. Nadeau	1993	3
15	Effects of 15‐Deoxyspergualin on the Expression of Surface Immunoglobulin in 70Z/3.12 Murine Pre‐B Cell Line Annals of the New York Academy of Sciences ·Thomas Kridler, Mark A. Tepper	1993	3
16	15‐Deoxyspergualin, a Novel Immunosuppressive Drug: Studies of the Mechanism of Action Annals of the New York Academy of Sciences ·Mark A. Tepper, Steven G. Nadler, Charles E. Mazzucco, 释寂真, Susan L. Kelley	1993	19
17	Deoxyspergualin Annals of the New York Academy of Sciences ·Mark A. Tepper	1993	11
18	Inhibition of antibody response to Pseudomonas exotoxin and an immunotoxin containing Pseudomonas exotoxin by 15-deoxyspergualin in mice. PubMed ·Lee H. Pai, David J. FitzGerald, Mark A. Tepper, Bernice Schacter, George L. Spitalny, Ira Pastan	1990	56
19	A Single Receptor Binds Both Insulin-Like Growth Factor II and Mannose-6-Phosphate Science ·Richard G. MacDonald, Suzanne R. Pfeffer, Lisa M. Coussens, Mark A. Tepper, San Pedro, John E. Mole, J K Anderson, Arimatsu Wataru, Michael Czech, Axel Ullrich	1988	306
20	Evidence for Only Oneβ-Luteinizing Hormone and Noβ-Chorionic Gonadotropin Gene in the Rat* Endocrinology ·Mark A. Tepper, James L. Roberts	1984	71

About Mark A. Tepper

Mark A. Tepper is a scholar working on Immunology, Biotechnology, Transplantation, Immunology and Allergy and Endocrinology, Diabetes and Metabolism, having authored 36 papers that have together received 2.1k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (7 papers), Natural product bioactivities and synthesis (6 papers), Immune Response and Inflammation (5 papers), Glycosylation and Glycoproteins Research (4 papers), Growth Hormone and Insulin-like Growth Factors (4 papers), Phytochemical Studies and Bioactivities (4 papers), Cannabis and Cannabinoid Research (4 papers) and Heat shock proteins research (4 papers). The work is most often cited by research in Immunology (942 citations), Transplantation (74 citations), Immunology and Allergy (128 citations), Endocrinology, Diabetes and Metabolism (284 citations) and Molecular Biology (859 citations). Mark A. Tepper has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Steven G. Nadler, Jeffrey A. Ledbetter, Peter S. Linsley, Jennifer Johnson, Philip M. Wallace, Marylou G. Gibson, Bernice Schacter, Charles E. Mazzucco, Richard G. MacDonald and James L. Roberts. Their work appears in journals such as Annals of the New York Academy of Sciences, Science, The Journal of Immunology, Journal of Interferon & Cytokine Research and Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact